Monét Stanford | Association for Accessible Medicines
New Blog - Inflation Rebate Proposal Builds on Bad Policy for Generics

Monét Stanford

Director, Policy
Monét Stanford

Monét Stanford is Director, Policy, of the Association for Accessible Medicines. She works with leadership to identify and respond to key policy issues affecting AAM members. Monét develops and manages research opportunities and writes testimony, public comments, policy papers and other materials in support of those positions. She also collaborates with AAM’s communications team on content that advances the strategic goals and mission of AAM.

Prior to joining AAM in May 2021, Monét managed government relations and regulatory affairs for Kaiser Permanente. There, she delivered pharmacy-based expertise during the pre-enactment evaluation of legislation and regulation; authored testimony to federal regulatory agencies, elected representatives and national advocacy organizations; developed a comprehensive regulatory analysis index; provided senior leadership with budget forecast projections in response to passed proposals; and served as the external contact for pharmacy issues. Before that, she served as a Policy Development Specialist at Centene Corporation. That role included developing and revising clinical algorithms to support formulary placement of specialty medicines.

Monét holds a Doctor of Pharmacy from the University of Maryland School of Pharmacy and a Bachelor of Arts in Health Policy and Administration from the University of Maryland Baltimore County. She completed her clinical residency training at Purdue University and formal policy training at the National Association for Chain Drug Stores.

Latest Tweets

Association for Accessible Medicines

202.249.7100

Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.